sequana_rgb_300.png
Press release: SEQUANA MEDICAL ANNOUNCES ADDITIONAL CONVERTIBLE FINANCING OF UP TO EUR 1.0 MILLION FROM EXISTING INVESTORS
October 23, 2024 01:00 ET | Sequana Medical NV
SEQUANA MEDICAL ANNOUNCES ADDITIONAL CONVERTIBLE FINANCING OF UP TO EUR 1.0 MILLION FROM EXISTING INVESTORS Ghent, Belgium, 23 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...
Persbericht: SEQUANA
Persbericht: SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN
October 21, 2024 12:00 ET | Sequana Medical NV
PERSBERICHT GEREGLEMENTEERDE INFORMATIE21 oktober 2024, 06:00 pm CEST SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN Gent, België, 21 oktober 2024 – Sequana...
Press release: SEQUA
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
October 21, 2024 12:00 ET | Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION21 October 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 21 October 2024 – Sequana Medical NV...
Persbericht: Transpa
Persbericht: Transparantiekennisgeving van Aandeelhouders
October 10, 2024 11:40 ET | Sequana Medical NV
Transparantiekennisgeving van Aandeelhouders Gent, België – 10 oktober 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (de "Vennootschap" of "Sequana Medical"), een pionier in de behandeling van...
Press release: Trans
Press release: Transparency Notification from Shareholders
October 10, 2024 11:40 ET | Sequana Medical NV
Transparency Notification from Shareholders Ghent, Belgium – 10 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...
sequana_rgb_300.png
Sequana Medical announces H1 2024 results and provides business update
September 30, 2024 17:55 ET | Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION30 September 2024, 23:55 CEST Sequana Medical announces H1 2024 results and provides business update alfapump® - US FDA approval anticipated...
sequana_rgb_300.png
SEQUANA MEDICAL ANNOUNCES CONVERTIBLE FINANCING OF UP TO EUR 6.1 MILLION FROM MAJOR SHAREHOLDERS
September 30, 2024 17:55 ET | Sequana Medical NV
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...
Persbericht: Transpa
Persbericht: Transparantiekennisgeving van Aandeelhouders
August 09, 2024 01:00 ET | Sequana Medical NV
Transparantiekennisgeving van Aandeelhouders Gent, België – 9 augustus 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (de "Vennootschap" of "Sequana Medical"), een pionier in de behandeling van...
Press release: Trans
Press release: Transparency Notification from Shareholders
August 09, 2024 01:00 ET | Sequana Medical NV
Transparency Notification from Shareholders Ghent, Belgium – 9 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...
sequana_rgb_300.png
Transparency Notification from Shareholders
August 05, 2024 12:00 ET | Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION 5 August 2024, 06 pm CEST Transparency Notification from Shareholders Ghent, Belgium – 5 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...